Helping investors discover, understand, and stay up-to-date on market news and investment opportunities within the Psychedelic industry.
Performance of psychedelic public companies this past week.
Optimi Health ($OPTI | $OPTHF) completed the largest legal natural psilocybin harvest in Canadian history. Optimi Health is licensed by Health Canada to produce and supply natural, EU-GMP grade psilocybin and other psychedelic substances. Press Release
MindMed ($MNMD | $MMED) provided positive results from their Phase II LSD study. The study found that acute administration of LSD produced long-lasting and notable reductions of anxiety and comorbid depression symptoms for up to 16 weeks. Press Release
Algernon Pharmaceuticals ($AGN | $AGNPF) will be the Headline Sponsor for Wonderland, the world’s largest conference in the psychedelic medicine sector, which will be held in Miami from November 3-5th. Press Release
PharmaTher Holdings ($PHRM | $PHRRF) completed an IND-enabling pharmacokinetic and tolerability study of KETARX Ketamine Patch. The ketamine patch demonstrated extended delivery of ketamine over 40 hours. Press Release
Nirvana Life Sciences ($NIRV) announced the development of a novel method of producing MDMA that reduces manufacturing time by two thirds. Nirvana has filed an Application with the US Patent Office for this new method. Press Release
BetterLife Pharma ($BETR | $BETRF) announced that they are working with their collaborators on a key research publication on BETR-001, their proprietary 2-bromo-LSD, and plans to submit it to a peer-reviewed journal by end of September. Press Release